VG-0604a

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVG-0604a
Drug Alias NameMDM2 inhibitor (MD Anderson Cancer Center)HDAC1 inhibitor (MD Anderson Cancer Centre)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionHistone deacetylase 1 inhibitorsp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2Histone deacetylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A